| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/23/2003 | CA2453784A1 A core formulation |
| 01/23/2003 | CA2453782A1 Core formulation comprising troglitazone and a biguanide |
| 01/23/2003 | CA2453775A1 Core formulation comprising pioglitazone hydrochloride and a biguanide |
| 01/23/2003 | CA2453399A1 Combinations for the treatment of inflammatory disorders |
| 01/23/2003 | CA2453389A1 Aerosol formulations of .delta.8 tetrahydrocannabinol |
| 01/23/2003 | CA2453384A1 Insert for the treatment of dry eye |
| 01/23/2003 | CA2453309A1 Peptide for regulation of tissue plasminogen activator |
| 01/23/2003 | CA2453216A1 Amphiphilic star-like macromolecules for drug delivery |
| 01/23/2003 | CA2453134A1 Method and device for coating pharmaceutical products |
| 01/23/2003 | CA2453111A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |
| 01/23/2003 | CA2452544A1 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 01/23/2003 | CA2452476A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 01/23/2003 | CA2452382A1 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 01/23/2003 | CA2451469A1 Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions |
| 01/23/2003 | CA2450896A1 Edibles containing edible optical elements and methods |
| 01/23/2003 | CA2449930A1 Pharmaceutical dispensing apparatus and method |
| 01/23/2003 | CA2448814A1 Composition for sustained release injections and production method thereof |
| 01/23/2003 | CA2448558A1 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 01/22/2003 | EP1277787A1 Method for preparing microsphere |
| 01/22/2003 | EP1277479A2 Alkali or alkaline earth metal benzoate particles |
| 01/22/2003 | EP1277471A1 Stable liquid preparation |
| 01/22/2003 | EP1277470A1 Injectable galenical formulation for use in photodynamic diagnostic or therapy and process of manufacturing it |
| 01/22/2003 | EP1277467A2 Non-chlorofluorocarbon aerosol formulations |
| 01/22/2003 | EP1277466A1 Patch containing anti-inflammatory agent |
| 01/22/2003 | EP1277465A1 Process for producing microsphere |
| 01/22/2003 | EP1277464A2 Liposome coated with polyhydroxyalkanoate and production method thereof |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276759A2 Reductive alkylation process on glycopeptides |
| 01/22/2003 | EP1276750A1 Antisense modulation of zinc finger protein-217 expression |
| 01/22/2003 | EP1276672A2 Improved method and apparatus for generating an aerosol |
| 01/22/2003 | EP1276508A2 A particulate complex for administering nucleic acid into a cell |
| 01/22/2003 | EP1276506A2 Sustained release drug compositions |
| 01/22/2003 | EP1276505A1 Mixtures of triblock polyesterpolyethylene glycol copolymers |
| 01/22/2003 | EP1276497A2 Mixture of defibrotide and g-csf and its use for activating haematopoietic progenitors |
| 01/22/2003 | EP1276495A1 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases |
| 01/22/2003 | EP1276474A2 Formulations for use in inhaler devices |
| 01/22/2003 | EP1276473A2 Pharmaceutical formulations for dry powder inhalers |
| 01/22/2003 | EP1276472A2 Formulations for use in inhaler devices |
| 01/22/2003 | EP1276471A2 Membrane delivery system |
| 01/22/2003 | EP1276470A2 Taste masking coating composition |
| 01/22/2003 | EP1276469A2 Taste masking coating composition |
| 01/22/2003 | EP1276468A1 Use of particulate vectors in immunomodulation |
| 01/22/2003 | EP1276467A2 Guaifenesin sustained release formulation and tablets |
| 01/22/2003 | EP1276466A2 Directly compressed solid dosage particles |
| 01/22/2003 | EP1276465A2 Improved water-insoluble drug particle process |
| 01/22/2003 | EP1276463A1 Hemostatic agent, method and carrier for applying a blood clotting agent |
| 01/22/2003 | EP1276462A2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 01/22/2003 | EP1276459A1 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 01/22/2003 | EP1276386A1 Chewing gum containing encapsulated abrasive filler substance |
| 01/22/2003 | EP1244485A4 Method and apparatus for locating the injection point of an implanted medical device |
| 01/22/2003 | EP1181029B1 Balsam for the treatment of surface burns and chafing rashes |
| 01/22/2003 | EP1158963B1 Controlled-release compositions of betahistine |
| 01/22/2003 | EP1079834B1 Stable compositions comprising levosimendan and alginic acid |
| 01/22/2003 | EP1053277B1 Composite particles containing an active substance |
| 01/22/2003 | EP0942721B1 Liquid composition comprising an hiv protease inhibitor and a c12-c18 fatty acid |
| 01/22/2003 | EP0868498B1 Blended pressure-sensitive adhesives |
| 01/22/2003 | EP0854731B1 Copolymeric micelle drug composition and method for the preparation thereof |
| 01/22/2003 | EP0853660B1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 01/22/2003 | EP0848948B1 Long-lasting composition for rectal administration |
| 01/22/2003 | EP0831777B1 Dinucleotides useful for the treatment of lung disease |
| 01/22/2003 | CN2531786Y External black plaster for treating hyperosteogeny |
| 01/22/2003 | CN2531760Y Adhesive stick for preventing snoring |
| 01/22/2003 | CN1392900A Alpha-isomaltosylglucosaccharide synthase, process for producing same and use thereof |
| 01/22/2003 | CN1392798A Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising same |
| 01/22/2003 | CN1392795A Novel tiotropiumonium-containing inhalation powder |
| 01/22/2003 | CN1391943A Chinese medicine paste for curing osteoarthropathy and preparing method |
| 01/22/2003 | CN1391932A Waist recovery plaster |
| 01/22/2003 | CN1391904A Nano hydroxy apatite calcium supplementing agent |
| 01/22/2003 | CN1391903A Microcapsule coated trace element product and its producing method |
| 01/22/2003 | CN1391900A Microcapsule coated liposoluble vitamin product and its producing method |
| 01/22/2003 | CN1391899A Aseptic freeze-dried prostaglandin injection and its preparing method and use |
| 01/22/2003 | CN1391898A Water soluble vitamin product coated with micro capsule and its producing method |
| 01/22/2003 | CN1391896A Quinoline keto derivatives medicinal composition and its preparing method |
| 01/22/2003 | CN1391895A New oral dosage form of Anethol Trithione |
| 01/22/2003 | CN1391894A Silybin injection containing cyclo dextrin or its derivatives |
| 01/22/2003 | CN1391893A Process for preparing simvastation drip pill |
| 01/22/2003 | CN1391890A Oral melbine hydrocloride slow-releasing prepn and its preparing method |
| 01/22/2003 | CN1391889A Tanshinone nano preparation and its preparing method |
| 01/22/2003 | CN1391888A Chinese medicine drink pill and its preparing method |
| 01/22/2003 | CN1391887A Superfine acanthopanax powder |
| 01/22/2003 | CN1391886A Medicine releasing control method for implanting type medical equipment |
| 01/22/2003 | CN1391880A Electric moxibustion instrument |
| 01/22/2003 | CN1391846A Chinese magnoliavine fruit super fine powder |
| 01/22/2003 | CN1099294C Process for preparing gingko injection |
| 01/22/2003 | CN1099285C Novel anti-spasmodic and anti-inflammatory agent composition and its process for manufacturing |
| 01/22/2003 | CN1099283C Slow releasing pill and its preparation |
| 01/22/2003 | CN1099282C Foaming agent fo r treating gynopathy and its preparing process |
| 01/21/2003 | US6509376 Utilization of dialkyfumarates |
| 01/21/2003 | US6509370 Paclitaxel formulation |
| 01/21/2003 | US6509350 Incorporating stabilizing effective amount of a hydrochloric acid donor to pharmaceutical formulation containing an active component subject to degradation |
| 01/21/2003 | US6509327 Instilling a therapeutically effective amount of a quinoline antibiotic composition in the affected ear to eradicate pathogenic Microbacterium species |
| 01/21/2003 | US6509322 Pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives |
| 01/21/2003 | US6509313 Stimulation of immune response with low doses of cytokines |
| 01/21/2003 | US6509044 Optically clear products having enhanced stability in syrup and bioavailability; surfactant matches fatty acid profile of oil soluble ingredient |
| 01/21/2003 | US6509042 Anti viral composition |
| 01/21/2003 | US6509040 Active ingredient, modified starch and matrix material; rapid dissolution in mouth; mechanically and chemically stable; delivering higher concentrations |
| 01/21/2003 | US6509038 Antifungal compositions with improved bioavailability |
| 01/21/2003 | US6509037 A modified sustained release salt of diclofenac tablet comprising hydroxyethyl cellulose, silicon dioxide and anhydrous lactose as channeling agent, polyvinylpyrrolidone, talc and magnesium stearate in speacific weight ratio |
| 01/21/2003 | US6509036 Effervescence as a penetration enhancer for drugs known, or suspected, of having poor bioavailability. |
| 01/21/2003 | US6509035 Oral preparation of coenzyme a useful for lowering blood lipid and a method producing for same |